Ostarine MK 2866 SARM Steroids For Muscle Wasting Treatment 841205-47-8

Ostarine MK 2866 SARM Steroids For Muscle Wasting Treatment 841205-47-8​

MK-2866 Quick Details:

MK-2866 Description:

MK-2866, also known as ostarine, is an investigational selective androgen receptor modulator (SARM) from GTX, Inc for treatment of conditions such as muscle wasting and osteoporosis. Selective androgen receptor modulators may be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids.

MK-2866 is selective in that it binds only to bone and muscle androgen receptors, which prevents things like prostate issues or hair loss or any of the other nasty side effects anabolic steroids can result in.

How MK-2866 works?

MK-2866 binds to your muscles receptors and causes steroid-like muscle growth without side effects. These gains are absolutely “keepable” and maintainable after use is discontinued, as long as workouts stay consistent and diet remains on track.

MK-2866 helps nutrient partitioning to a high degree.

The versatility and safety of ostarine make it a godsend to fitness enthusiasts everywhere. Whether they are looking for a virtually side effect free alternative to steroids in between cycles, a safe non-toxic advantage in healing injuries, or just a significant edge when cutting down stubborn fat stores, MK-2866 is the front-man in the magical world of SARMs.

Mk-2866 has proven to be quite beneficial in healing and perhaps preventing injuries in tendons, bone, and ligaments. Studies have shown, it is better than testosterone at injury prevention.

As a result, Mk-2866 has become a favorite of many crossfitters and bodybuilders who sustain injuries during training. Also, Mk-2866 shows potential for use in the treatment of muscle wasting diseases, osteoporosis, and other ailments.

Mini-PCT for 12 Week MK-2866 (Ostarine Cycle):

Use on PCT:

Since MK-2866 isn't suppressive at 25mg in a 4 week cycle, it can be tactfully used in post cycle therapy, as long as dose and duration is controlled. Longer cycles of mk-2866 are common and tend to be around the 8-12 week mark. They still have minimal effect on the HPTA.

Example MK-2866 Based PCT (after a Testosterone/Dianabol cycle):

Our Major Market: United_States, United_Kingdom, Australia, Canada, Sweden, Russia, Poland, Brazil, Israel, Netherlands, Germany, Puerto_Rico, Uzbekistan, Japan, Spain, Switzerland, Poland and on on.